// App-Quantinova.ai

e15641 : Next-generation sequencing (NGS) in an advanced hepatocellular carcinoma (HCC) cohort: Analysis of common mutations, clinical covariates, and overall survival (OS).

Researchers

Presenter

  • Robin Kate Kelley

Principal Investigators

  • Paige M. Bracci

  • John Dozier Gordan

  • Kimberley Evason

  • Nancy M. Joseph

  • Andrea Grace Bocobo

  • Blake K. Rosenthal

  • Hubert J. Stoppler

  • Halla Sayed Nimeiri

  • Alan P. Venook

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • University of Utah, Salt Lake City, UT

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Advanced biliary tract carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Temsirolimus

  • Sorafenib

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • NCT01008917

  • NCT01687673

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved